Translational and tailored, but can we afford it?

Use of electronic data to raise the standard of cancer care

Online collaborations to aid treatment development

WINTHER: The WIN therapeutics clinical trial

Use of genetic variance to identify potential therapeutic targets

Building international collaborations and the WINTHER trial

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Cancer genes differ in different parts of a tumour

Endocrine therapy resistance and next generation sequencing

Molecular characterisation of breast cancer: the mutational landscape

Analysis of the development of breast tissue

Myelodysplastic syndrome drug development and combination therapy